Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 6,424 |
Reported balance
After 2026-06-25 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 645 · Balance 6,424 F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 6,846 |
Reported balance
After 2026-06-25 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-25 · Grant · Acquired 422 · Balance 6,846 F2: At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant. |
| Common Stock Class ASEC Table I · non-derivative | IndirectBy Firm | 185 |
Reported balance
Holding disclosure · report date 2026-06-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 185 |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Partnership | 0.375 |
Reported balance
Holding disclosure · report date 2026-06-25 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 0.375 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
F2: At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 29, 2026 20:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 422 | $225.00 | $94,950.00 |
DisclosureSEC source: 0001341358-26-000003 · wk-form4_1782763903.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 6,846 F2 · kind: At the Reporting Person's election, shares issued in lieu of all or a portion of the annual cash retainer for serving as a member of the Board of Directors. The number of shares was determined by dividing the cash retainer by the closing price on the date of grant. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 645 | $225.00 | $145,125.00 |
DisclosureSEC source: 0001341358-26-000003 · wk-form4_1782763903.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 6,424 F1 · kind: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 879 | $273.03 | $239,993.37 |
DisclosureSEC source: 0001156375-25-000163 · wk-form4_1750977262.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 5,779 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 13:10 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 350 | $265.35 | $92,872.50 |
DisclosureSEC source: 0001156375-25-000134 · wk-form4_1749647414.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 4,900 Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 13:10 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 150 | $265.36 | $39,804.00 |
DisclosureSEC source: 0001156375-25-000134 · wk-form4_1749647414.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 5,250 Read SEC document |
| May 15, 2025 Filed May 19, 2025 13:03 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,000 | $272.56 | $817,680.00 |
DisclosureSEC source: 0001156375-25-000123 · wk-form4_1747659794.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 5,400 F1 · price: On May 15, 2025, Mr. Carey sold an aggregate of 3,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $272.21 to $272.90. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:48 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,237 | $194.10 | $240,101.70 |
DisclosureSEC source: 0001156375-24-000132 · wk-form4_1719449284.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 8,400 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 14:19 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,000 | $195.44 | $586,320.00 |
DisclosureSEC source: 0001156375-24-000093 · wk-form4_1718374773.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 7,163 Read SEC document |
| October 10, 2023 Filed Mar 15, 2024 20:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleClass B Common Stock, Series B-4 | 1 | $216.09 | $216.09 |
DisclosureSEC source: 0001156375-24-000016 · wk-form5_1710534001.xml · nonDerivative · entry 7 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Partnership Disclosed balance after: 0 F3 · shares: This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-4 share was sold on October 10, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 10, 2023 was $216.09. Read SEC document |
| October 09, 2023 Filed Mar 15, 2024 20:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleClass B Common Stock, Series B-3 | 1 | $215.76 | $215.76 |
DisclosureSEC source: 0001156375-24-000016 · wk-form5_1710534001.xml · nonDerivative · entry 6 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Partnership Disclosed balance after: 0 F2 · shares: This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-1 share and one Class B-3 share were sold on October 9, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 9, 2023 was $215.76 Read SEC document |
| October 09, 2023 Filed Mar 15, 2024 20:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleClass B Common Stock, Series B-1 | 1 | $215.76 | $215.76 |
DisclosureSEC source: 0001156375-24-000016 · wk-form5_1710534001.xml · nonDerivative · entry 5 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Partnership Disclosed balance after: 0 F2 · shares: This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-1 share and one Class B-3 share were sold on October 9, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 9, 2023 was $215.76 Read SEC document |
| October 06, 2023 Filed Mar 15, 2024 20:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleClass B Common Stock, Series B-2 | 1 | $211.93 | $211.93 |
DisclosureSEC source: 0001156375-24-000016 · wk-form5_1710534001.xml · nonDerivative · entry 4 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Partnership Disclosed balance after: 0 F1 · shares: This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-2 share was sold on October 6, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 6, 2023 was $211.93. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:14 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,342 | $178.89 | $240,070.38 |
DisclosureSEC source: 0001156375-23-000094 · wf-form4_168796886007112.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 10,163 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 14:29 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,146 | $209.44 | $240,018.24 |
DisclosureSEC source: 0001156375-22-000189 · wf-form4_165651295045134.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 8,821 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,500 | $244.11 | $366,166.80 |
DisclosureSEC source: 0001156375-22-000062 · wf-form4_164488928926758.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 7,675 Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:41 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,500 | $244.60 | $366,905.70 |
DisclosureSEC source: 0001156375-22-000062 · wf-form4_164488928926758.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 9,175 Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000032 · wf-form4_164322857525506.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 4,719 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Feb 15, 2022 00:48 UTC Amendment | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000055 · wf-form4a_164488610360070.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,675 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. F2 · balance_after: The original Form 4 filed on January 26, 2022 incorrectly reported 4,719 shares held indirectly through Mr. Carey's Trust. This amendment is being filed to correctly report the amount as 10,675 shares held indirectly through Mr. Carey' Trust. Read SEC document |
| December 31, 2021 Filed Feb 15, 2022 00:47 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000054 · wf-form5_164488601207836.xml · nonDerivative · entry 4 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 185 F1 · balance_after: This Form 5 is being filed to reflect the correct allocation of Mr. Carey's shares that are held indirectly as of December 31, 2021, which were incorrectly reflected on his prior filings. Read SEC document |
| December 31, 2021 Filed Feb 15, 2022 00:47 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000054 · wf-form5_164488601207836.xml · nonDerivative · entry 3 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,600 F1 · balance_after: This Form 5 is being filed to reflect the correct allocation of Mr. Carey's shares that are held indirectly as of December 31, 2021, which were incorrectly reflected on his prior filings. Read SEC document |
| July 13, 2021 Filed Feb 15, 2022 00:47 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 6,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000054 · wf-form5_164488601207836.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 0 Read SEC document |
| July 13, 2021 Filed Feb 15, 2022 00:47 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 6,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000054 · wf-form5_164488601207836.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,785 F1 · balance_after: This Form 5 is being filed to reflect the correct allocation of Mr. Carey's shares that are held indirectly as of December 31, 2021, which were incorrectly reflected on his prior filings. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 23:54 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 917 | $218.12 | $200,016.04 |
DisclosureSEC source: 0001156375-21-000066 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 4,644 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 22:14 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,000 | $168.01 | $336,020.00 |
DisclosureSEC source: 0001156375-20-000084 · edgardoc.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 6,141 F2 · price: On August 11, 2020, Mr. Carey sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $167.98 to $168.11. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:14 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 6,000 | $164.51 | $987,060.00 |
DisclosureSEC source: 0001156375-20-000084 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 8,141 F1 · price: On August 10, 2020, Mr. Carey sold an aggregate of 6,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $163.90; $164.00 to $164.85; and $165.00 to $165.50. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:08 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000052 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 3,727 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:28 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000059 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 2,541 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| May 08, 2019 Filed May 9, 2019 16:51 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,000 | $178.62 | $714,480.00 |
DisclosureSEC source: 0001156375-19-000041 · edgardoc.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 14,141 F2 · price: On May 8, 2019, Mr. Carey sold an aggregate of 4,000 shares of CME Group Class A common Stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales prices has been reported. The price range was $178.49 to $178.74. Read SEC document |
| May 07, 2019 Filed May 9, 2019 16:51 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 6,000 | $179.29 | $1,075,740.00 |
DisclosureSEC source: 0001156375-19-000041 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 18,141 F1 · price: On May 7, 2019, Mr. Carey sold an aggregate of 6,000 shares of CME Group Class A common Stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales prices has been reported. The price ranges were: $178.83 to $178.93 and $179.02 to $179.80. Read SEC document |
| November 21, 2018 Filed Nov 23, 2018 14:58 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,000 | $192.15 | $384,300.00 |
DisclosureSEC source: 0001156375-18-000134 · primary_doc.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Firm Disclosed balance after: 24,141 F2 · price: On November 21, 2018, Mr. Carey sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices with a $1 range have been aggregated and the weighted average has been reported. The price range was $191.85 to $192.44. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 20, 2018 Filed Nov 23, 2018 14:58 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 3,000 | $191.64 | $574,920.00 |
DisclosureSEC source: 0001156375-18-000134 · primary_doc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Firm Disclosed balance after: 26,141 F1 · price: On November 20, 2018, Mr. Carey sold an aggregate of 3,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices with a $1 range have been aggregated and the weighted average has been reported. The price range was $191.04 to $191.90. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 22:47 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,800 | $183.45 | $513,660.00 |
DisclosureSEC source: 0001156375-18-000129 · primary_doc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,532 F1 · price: On November 2, 2018, Mr. Carey sold an aggregate of 2,800 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price range was $183.30 to $183.64 The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:04 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000104 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 4,332 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:38 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000058 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 4,159 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 22:01 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000074 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,294 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.